pubmed-article:3592787 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0003864 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0043405 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0027950 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0162772 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0001314 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0439793 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0205156 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C0600210 | lld:lifeskim |
pubmed-article:3592787 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
pubmed-article:3592787 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3592787 | pubmed:dateCreated | 1987-7-16 | lld:pubmed |
pubmed-article:3592787 | pubmed:abstractText | Polymorphonuclear leucocyte (PMN) functions (migration in vitro, chemiluminescence, O-2 production, binding of chemotactic peptide, and aggregation) were studied in HLA-B27 positive patients with previous yersinia arthritis (YA). PMNs of patients whose disease had been severe showed chemokinetic and chemiluminescence responses significantly higher than the PMNs of those with a mild disease. The results support the view that enhanced PMN function contributes to inflammatory symptoms in patients with YA. | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:language | eng | lld:pubmed |
pubmed-article:3592787 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3592787 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3592787 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3592787 | pubmed:month | Apr | lld:pubmed |
pubmed-article:3592787 | pubmed:issn | 0003-4967 | lld:pubmed |
pubmed-article:3592787 | pubmed:author | pubmed-author:RepoHH | lld:pubmed |
pubmed-article:3592787 | pubmed:author | pubmed-author:Leirisalo-Rep... | lld:pubmed |
pubmed-article:3592787 | pubmed:author | pubmed-author:Koivuranta-Va... | lld:pubmed |
pubmed-article:3592787 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3592787 | pubmed:volume | 46 | lld:pubmed |
pubmed-article:3592787 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3592787 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3592787 | pubmed:pagination | 307-13 | lld:pubmed |
pubmed-article:3592787 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:meshHeading | pubmed-meshheading:3592787-... | lld:pubmed |
pubmed-article:3592787 | pubmed:year | 1987 | lld:pubmed |
pubmed-article:3592787 | pubmed:articleTitle | Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease. | lld:pubmed |
pubmed-article:3592787 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3592787 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3592787 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3592787 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3592787 | lld:pubmed |